Patent 7582440 was granted and assigned to Cancer Research Technology Limited on September, 2009 by the United States Patent and Trademark Office.
The present invention relates to endothelial cell-specific genes and encoded polypeptides and materials and uses thereof in the imaging, diagnosis and treatment of conditions involving the vascular endothelium.